Biogen IDEC Inc. Quarterly Valuation – July 2014 $BIIB
Biogen qualifies for the Enterprising Investor but not the Defensive Investor. The Defensive Investor has concerns with the short dividend record and the high PEmg and PB ratios, while the Enterprising Investor’s only concern is the lack of dividend payments.
Vertex Pharmaceuticals Annual Valuation – 2014 $VRTX
Vertex Pharmaceuticals does not qualify for either the Defensive Investor or the Enterprising Investor. The Defensive Investor has major concerns with the lack of earnings stability over the last ten years, the lack of dividends, the insufficient earnings growth, and the high PEmg and PB ratios.
Abbott Labs Quarterly Valuation – June 2014 $ABT
Abbott Labs is suitable for the Enterprising Investor but not the Defensive Investor, who is concerned with the low current ratio and the lack of sufficient earnings growth over the last ten years. The Enterprising Investor is only concerned with the lack of earnings growth over the last five years.
Pfizer Inc. Quarterly Valuation – June 2014 $PFE
Pfizer achieves a rare feat, which is satisfying all of the requirements of both the Defensive Investor and the Enterprising Investor. Not many companies meet this level of low-risk, and as a result, both investor types should have few concerns about the financial stability of the company.
McKesson Corp (MCK) Annual Valuation – 2014
McKesson Corp is not suitable for either the Defensive Investor or the Enterprising Investor. The Defensive Investor has concerns with the low current ratio, lack of earnings stability over the last ten years, and the high PEmg and PB ratios, while the Enterprising Investor is concerned with the high level of debt relative to the current assets.
Regeneron Pharmaceuticals Inc. (REGN) Annual Valuation – 2014
Regeneron Pharmaceuticals is not suitable for either the Defensive Investor or the Enterprising Investor. For the Defensive Investor, the company has shown insufficient earnings stability or growth over the ten year historical period, does not pay dividends, and is trading at a high PEmg ratio.